Sehat Kahani, a Women-led Pakistani telehealth startup, raised $2.7 million in Series A funding.
Health tech fund Amaanah Circle from Singapore led the investment round with participation from Epic Angels, Cross Fund, USAID Investment Promotion Activity, Augmentor, Impact Investment Exchange, and the Elahi Group of Companies.
Founded in 2017 by two women doctors, Dr. Sara Saeed Khurram and Dr. Iffat Zafar Aga, Sehat Kahani has made significant strides in the healthcare sector. Their mission is clear: to bridge the gap between patients and healthcare providers through innovative solutions.
Sehat Kahani boasts an impressive promise of connecting patients with its extensive network of 7,500 doctors within a mere 60 seconds. The startup also offers on-demand at-home or on-site laboratory services and online medicine delivery. Catering to both civilian and corporate clients, its mobile application is now being used by patients in over 310 cities and towns in Pakistan, more than 800 corporations, and 62 e-health clinics.
The Pakistani telmedicine startup said it Sehat Kahani plans to leverage new funds to develop its predictive AI for telehealth and offer precision medicine at scale. “This funding infusion marks a pivotal moment for Sehat Kahani. It will enable us to develop advanced features, including decision support systems, precision medicine tools, and predictive AI models to help our patients live fully by knowing their disease better,” Dr Khurram said in a statement.
According to the Health IT Media funding database — digital health companies have raised more than $120 billion in venture capital funding to date. However, there has not been much funding raised for Pakistani startups in digital health recently. The previously reported investing event was in 2021 when Ailaaj, a vertically integrated primary healthcare platform that offers telemedicine services, secured $1.6 million in seed funding. Marham, which claims to be Pakistan’s first telehealth startup, also scored $1 million in seed funding in the same year.